STOCK TITAN

[SCHEDULE 13D/A] BRF S.A. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Amendment No. 1 to Schedule 13D reports that SALIC Investment executed a public sale of 185,556,900 common shares of BRF S.A. at a net price of approximately R$19.96 per share via an auction on B3, which settled on September 4, 2025. Concurrent with the sale, SALIC entered a cash-settled derivative referencing the same 185,556,900 shares with an unaffiliated dealer, including an upfront payment by SALIC and ongoing non-refundable fees. The derivative permits SALIC to elect cash settlement prior to expiry and is scheduled to expire on September 2, 2026. As a result of the disposition, the reporting persons ceased to be beneficial owners of more than 5% of BRF common shares.

Emendamento No. 1 al Schedule 13D riferisce che SALIC Investment ha eseguito una vendita pubblica di 185.556.900 azioni ordinarie di BRF S.A. a un prezzo netto di circa R$ 19,96 per azione, tramite un’asta su B3, il regolamento si è perfezionato il 4 settembre 2025. Contemporaneamente alla vendita, SALIC ha stipulato un derivato regolato in contanti riferito alle stesse 185.556.900 azioni con un dealere non affiliato, includendo un pagamento iniziale da parte di SALIC e oneri ricorrenti non rimborsabili. Il derivato consente a SALIC di optare per la liquidazione in contanti prima della scadenza ed è previsto scadere il 2 settembre 2026. In seguito alla disposizione, i soggetti segnalanti hanno cessato di essere beneficiari effettivi di oltre il 5% delle azioni ordinarie di BRF.

Enmienda No. 1 al Schedule 13D informa que SALIC Investment llevó a cabo una venta pública de 185.556.900 acciones ordinarias de BRF S.A. a un precio neto de aproximadamente R$19,96 por acción, mediante una subasta en B3, cuyo liquidación se llevó a cabo el 4 de septiembre de 2025. Paralelamente a la venta, SALIC pactó un derivado liquidado en efectivo referenciado a las mismas 185.556.900 acciones con un comerciante no afiliado, incluyendo un pago inicial por parte de SALIC y tasas no reembolsables continuas. El derivado permite a SALIC optar por la liquidación en efectivo antes del vencimiento y está previsto que expire el 2 de septiembre de 2026. Como resultado de la disposición, las personas informantes dejaron de ser titulares beneficiarios de más del 5% de las acciones ordinarias de BRF.

Schedule 13D 제1차 수정은 SALIC Investment가 BRF S.A.의 보통주 185,556,900주를 B3의 경매를 통해 순가 약 19.96브라질 레이얼(주당)로 매각했고, 정산은 2025년 9월 4일에 이루어졌다고 보고합니다. 매각과 동시에 SALIC은 동일한 185,556,900주를 기초로 한 현금결제 파생상품을 비계열 딜러와 체결했으며, SALIC의 선지급금 및 지속적인 환불 불가 수수료가 포함됩니다. 이 파생상품은 만료 전에 현금정산을 선택할 수 있게 해주며, 만료일은 2026년 9월 2일로 예정되어 있습니다. 이 처분으로 보고당사자들은 BRF 보통주 5%를 초과하는 유익한 소유권을 더 이상 보유하지 않게 되었습니다.

1er amendement au Schedule 13D indique que SALIC Investment a procédé à une vente publique de 185 556 900 actions ordinaires de BRF S.A. à un prix net d’environ 19,96 R$ par action, lors d’une enchère sur B3, dont la liquidation a eu lieu le 4 septembre 2025. Parallèlement à la vente, SALIC a conclu avec un négociant non affilié un dérivé réglé en espèces référencé sur les mêmes 185 556 900 actions, incluant un paiement initial de SALIC et des frais non remboursables continus. Le dérivé permet à SALIC d’opter pour un règlement en espèces avant l’expiration et il est prévu d’expirer le 2 septembre 2026. Suite à cette disposition, les personnes déclarantes ne sont plus bénéficiaires effectifs de plus de 5% des actions ordinaires de BRF.

Änderung Nr. 1 zum Schedule 13D berichtet, dass SALIC Investment einen öffentlichen Verkauf von 185.556.900 Stammaktien der BRF S.A. zu einem Nettopreis von ca. 19,96 R$ pro Aktie über eine Auktion an der B3 durchgeführt hat, der am 4. September 2025 abgewickelt wurde. Zugleich hat SALIC mit einem nicht verbundenen Händler ein cash-settled Derivat abgeschlossen, das auf denselben 185.556.900 Aktien basiert und eine anfängliche Zahlung von SALIC sowie fortlaufende nicht erstattungsfähige Gebühren umfasst. Das Derivat ermöglicht SALIC, vor Fälligkeit eine bar Abrechnung zu wählen, und es soll am 2. September 2026 verfallen. Infolge der Veräußerung haben die meldenden Personen aufgehört, vorteilhafte Eigentümer von mehr als 5% der BRF-Stammaktien zu sein.

التعديل رقم 1 على الجدول 13D يفيد بأن SALIC Investment نفذت بيعاً عاماً ل185,556,900 سهماً عادياً من BRF S.A. بسعر صافي يقرب من 19.96 ريال برازيلي للسهم الواحد، من خلال مزاد على B3، وتم التسوية في 4 سبتمبر 2025. بالتزامن مع البيع، أبرمت SALIC عقداً مشتقاً مدفوعاً نقداً يشير إلى نفس هذه الأسهم الـ185,556,900 مع تاجر غير تابع، يشمل دفعة مقدمة من SALIC ورسوم غير قابلة للاسترداد مستمرة. يتيح المشتق لـ SALIC اختيار التسوية النقدية قبل انتهاء المدة ومن المقرر أن ينتهي في 2 سبتمبر 2026. نتيجة لهذا التصرف، لم يعد الأشخاص المبلّغون يمتلكون حقوقاً مستفيدة تفوق 5% من أسهم BRF العادية.

对 Schedule 13D 的修订案第1号 报告称 SALIC Investment 以每股约 19.96 雷亚尔的净价通过在 B3 的拍卖公开出售 BRF S.A. 的 185,556,900 股普通股,成交日为 2025 年 9 月 4 日。与出售同时,SALIC 与一名非关联交易商签订了一份以同样的 185,556,900 股为标的、现金结算的衍生品,其中包含 SALIC 的前期款项及持续的不可退款费用。该衍生品允许 SALIC 在到期前选择现金结算,预计于 2026 年 9 月 2 日到期。因该处置,申报人不再是 BRF 普通股超过 5% 的受益所有人。

Positive
  • Large, orderly disposition of 185,556,900 shares via an auction on B3 at an identified net price of R$19.96 per share
  • Full disclosure of the concurrent cash-settled derivative and its key commercial features, including upfront payment and expiry date of September 2, 2026
Negative
  • Reporting persons ceased to be beneficial owners of more than 5% of BRF common shares, indicating reduced disclosed influence
  • Derivative retains potential economic exposure despite the disposition, which may complicate assessments of actual change in economic interest

Insights

TL;DR Sale of 185,556,900 BRF shares and a linked cash-settled derivative reduced SALIC's holdings below 5%, removing its >5% beneficial ownership status.

The filing documents a material disposition: 185,556,900 shares sold at ~R$19.96 per share settled September 4, 2025. The concurrent cash-settled derivative references the identical share amount, includes an upfront payment and quarterly fees, and allows SALIC to trigger cash settlement prior to an expiry currently set for September 2, 2026. The structure suggests SALIC retained economic exposure via the derivative while transferring legal ownership. The reporting persons now report 0% beneficial ownership on the cover pages.

TL;DR Reporting persons formally relinquished >5% beneficial ownership while documenting a structured derivative tied to the disposed shares.

The amendment clarifies that the Reporting Persons executed a disposition through an auction and concurrently entered a cash-settled derivative with a dealer. The derivative involves upfront and quarterly non-refundable payments and contemplates cash settlement either upon exercise or at expiry on September 2, 2026. The filing discloses cessation of >5% beneficial ownership but continues to record the derivative relationship, which is relevant for governance and disclosure because it preserves potential economic exposure despite the disposition.

Emendamento No. 1 al Schedule 13D riferisce che SALIC Investment ha eseguito una vendita pubblica di 185.556.900 azioni ordinarie di BRF S.A. a un prezzo netto di circa R$ 19,96 per azione, tramite un’asta su B3, il regolamento si è perfezionato il 4 settembre 2025. Contemporaneamente alla vendita, SALIC ha stipulato un derivato regolato in contanti riferito alle stesse 185.556.900 azioni con un dealere non affiliato, includendo un pagamento iniziale da parte di SALIC e oneri ricorrenti non rimborsabili. Il derivato consente a SALIC di optare per la liquidazione in contanti prima della scadenza ed è previsto scadere il 2 settembre 2026. In seguito alla disposizione, i soggetti segnalanti hanno cessato di essere beneficiari effettivi di oltre il 5% delle azioni ordinarie di BRF.

Enmienda No. 1 al Schedule 13D informa que SALIC Investment llevó a cabo una venta pública de 185.556.900 acciones ordinarias de BRF S.A. a un precio neto de aproximadamente R$19,96 por acción, mediante una subasta en B3, cuyo liquidación se llevó a cabo el 4 de septiembre de 2025. Paralelamente a la venta, SALIC pactó un derivado liquidado en efectivo referenciado a las mismas 185.556.900 acciones con un comerciante no afiliado, incluyendo un pago inicial por parte de SALIC y tasas no reembolsables continuas. El derivado permite a SALIC optar por la liquidación en efectivo antes del vencimiento y está previsto que expire el 2 de septiembre de 2026. Como resultado de la disposición, las personas informantes dejaron de ser titulares beneficiarios de más del 5% de las acciones ordinarias de BRF.

Schedule 13D 제1차 수정은 SALIC Investment가 BRF S.A.의 보통주 185,556,900주를 B3의 경매를 통해 순가 약 19.96브라질 레이얼(주당)로 매각했고, 정산은 2025년 9월 4일에 이루어졌다고 보고합니다. 매각과 동시에 SALIC은 동일한 185,556,900주를 기초로 한 현금결제 파생상품을 비계열 딜러와 체결했으며, SALIC의 선지급금 및 지속적인 환불 불가 수수료가 포함됩니다. 이 파생상품은 만료 전에 현금정산을 선택할 수 있게 해주며, 만료일은 2026년 9월 2일로 예정되어 있습니다. 이 처분으로 보고당사자들은 BRF 보통주 5%를 초과하는 유익한 소유권을 더 이상 보유하지 않게 되었습니다.

1er amendement au Schedule 13D indique que SALIC Investment a procédé à une vente publique de 185 556 900 actions ordinaires de BRF S.A. à un prix net d’environ 19,96 R$ par action, lors d’une enchère sur B3, dont la liquidation a eu lieu le 4 septembre 2025. Parallèlement à la vente, SALIC a conclu avec un négociant non affilié un dérivé réglé en espèces référencé sur les mêmes 185 556 900 actions, incluant un paiement initial de SALIC et des frais non remboursables continus. Le dérivé permet à SALIC d’opter pour un règlement en espèces avant l’expiration et il est prévu d’expirer le 2 septembre 2026. Suite à cette disposition, les personnes déclarantes ne sont plus bénéficiaires effectifs de plus de 5% des actions ordinaires de BRF.

Änderung Nr. 1 zum Schedule 13D berichtet, dass SALIC Investment einen öffentlichen Verkauf von 185.556.900 Stammaktien der BRF S.A. zu einem Nettopreis von ca. 19,96 R$ pro Aktie über eine Auktion an der B3 durchgeführt hat, der am 4. September 2025 abgewickelt wurde. Zugleich hat SALIC mit einem nicht verbundenen Händler ein cash-settled Derivat abgeschlossen, das auf denselben 185.556.900 Aktien basiert und eine anfängliche Zahlung von SALIC sowie fortlaufende nicht erstattungsfähige Gebühren umfasst. Das Derivat ermöglicht SALIC, vor Fälligkeit eine bar Abrechnung zu wählen, und es soll am 2. September 2026 verfallen. Infolge der Veräußerung haben die meldenden Personen aufgehört, vorteilhafte Eigentümer von mehr als 5% der BRF-Stammaktien zu sein.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
Sovereign Wealth Fund of Saudi Arabia


SCHEDULE 13D


SALIC International Investment Company
Signature:/s/ Sulaiman AlRumaih
Name/Title:Sulaiman AlRumaih, Chief Executive Officer
Date:09/04/2025
Saudi Agricultural and Livestock Investment Company
Signature:/s/ Sulaiman AlRumaih
Name/Title:Sulaiman AlRumaih, Chief Executive Officer
Date:09/04/2025
The Public Investment Fund
Signature:/s/ Yasir O. AlRumayyan
Name/Title:Yasir O. AlRumayyan, Governor
Date:09/04/2025

FAQ

What did SALIC sell in the BRFS filing?

SALIC sold 185,556,900 common shares of BRF S.A. at a net price of approximately R$19.96 per share via an auction on B3.

When did the BRFS transaction settle?

The sale settled on September 4, 2025 as stated in the Schedule 13D amendment.

Did the reporting persons keep any exposure to BRF after the sale?

Yes. Substantially concurrently, SALIC entered a cash-settled derivative referencing the same 185,556,900 shares, with an expiry of September 2, 2026.

Do the reporting persons still own more than 5% of BRF (BRFS)?

No. The filing states that as a result of the disposition, the reporting persons ceased to be beneficial owners of more than 5% of the outstanding common shares.

What are the payment terms for the derivative in the BRFS filing?

SALIC agreed to an upfront payment based on the initial reference price for 185,556,900 shares and certain other non-refundable fees payable upfront and on a quarterly basis.
BRF SA

NYSE:BRFS

BRFS Rankings

BRFS Latest News

BRFS Latest SEC Filings

BRFS Stock Data

5.38B
752.17M
53.04%
3.84%
0.84%
Packaged Foods
Consumer Defensive
Link
Brazil
São Paulo